Literature DB >> 1623342

Subungual melanoma: a clinico-pathological study of 24 cases.

H S Rigby1, J C Briggs.   

Abstract

Twenty-four patients with subungual melanoma (13 women and 11 men) had a mean age of 61.6 years. Twenty-two lesions arose either on the thumb or hallux. The mean delay before diagnosis was 30 months. Two patients presented with stage two melanoma and three of the melanomas were in situ lesions (Clark level 1). Nineteen melanomas were Clark level 4 or 5 and the mean thickness of the invasive melanomas was 4.7 mm. Seven patients died of metastatic disease (mean survival 10 months, range 6-50 months). Clark level, thickness and mitotic activity of the melanomas correlated with poor clinical outcome. Delay in presentation and the presence of advanced disease contribute to the poor prognosis of this tumour.

Entities:  

Mesh:

Year:  1992        PMID: 1623342     DOI: 10.1016/0007-1226(92)90051-x

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  5 in total

1.  Subungual melanoma with osteocartilaginous differentiation.

Authors:  H Giele; K Hollowood; C L M H Gibbons; D J Wilson; N A Athanasou
Journal:  Skeletal Radiol       Date:  2003-10-08       Impact factor: 2.199

2.  Acral lentiginous melanoma in the Turkish population and a new dermoscopic clue for the diagnosis.

Authors:  Fezal Ozdemir; Micol A Errico; Banu Yaman; Isil Karaarslan
Journal:  Dermatol Pract Concept       Date:  2018-04-30

3.  Nail Apparatus Melanoma: Experience of 10 Years in a Single Institution.

Authors:  Desiree Ji Re Lee; Samia Trigo Arbache; Maria Victória Quaresma; Marcello Menta Simonsen Nico; Tatiana Villas Boas Gabbi
Journal:  Skin Appendage Disord       Date:  2018-07-03

4.  Relearning the lesson -- amelanotic malignant melanoma: a case report.

Authors:  Ezekiel Oburu; Alberto Gregori
Journal:  J Med Case Rep       Date:  2008-01-31

5.  Acral Melanoma in Chinese: A Clinicopathological and Prognostic Study of 142 cases.

Authors:  Jiaojie Lv; Bo Dai; Yunyi Kong; Xuxia Shen; Jincheng Kong
Journal:  Sci Rep       Date:  2016-08-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.